surmount trials tirzepatide SURMOUNT-2: confers about 15% weight loss in adults with obesity and diabetes Tirzepatide after intensive lifestyle intervention

Compare 37 GLP-1 weight loss doctors and clinics in San Francisco, California

on the healthcare industry.

With the growing burden of metabolic disease, cardiovascular disease, and diabetes mellitus, there is an implication for new pharmacological intervention

However, it is not clear what kind of administration fre...

The mean differences in serum electrolytes between T2DM patients and non-diabetic participants were compared using the Mann-Whitney U test, and correlation analysis was performed

This literature review focuses on the underlying mechanisms linking antipsychotics and mood stabilizers to weight gain in bipolar disorder